Tarsier Pharma Ltd. filed a Form F-1 registration statement for an initial public offering on 2026-04-21. It has amended it 5 times. As of its latest filing, on 2026-07-16, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have applied to list our ordinary shares on the New York Stock Exchange (the “NYSE”) under the symbol “TARX”.From the F-1/A filed 2026-07-16
Use of proceeds
We currently intend to use the net proceeds from this offering as described in “Use of Proceeds . ” You will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used in a manner which you may consider most appropriate.From the F-1/A filed 2026-07-16
Net loss or income
Our net loss for the years ended December 31, 2024 and 2025 were $2,456 thousand and $5,070 thousand, respectively.From the F-1/A filed 2026-07-16
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2026-04-21 | Registration statement filed (foreign issuer) | F-1 |
| 2026-05-18 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-06-08 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-06-16 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-07-15 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-07-16 | Registration statement amended (foreign issuer) | F-1/A |
Tools for this story
Each opens in a new tab, filled in for Tarsier Pharma Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.